References
- Volkow ND, McLellan AT. Opioid abuse in chronic pain: misconceptions and mitigation strategies. Longo DL, ed. N Engl J Med. 2016;374(13):1253–1263.
- McCabe SE, West BT, Morales M, Cranford JA, Boyd CJ. Does early onset of non-medical use of prescription drugs predict subsequent prescription drug abuse and dependence? Results from a national study. Addiction. 2007;102(12):1920–1930.
- Schuckit MA. A brief history of research on the genetics of alcohol and other drug use disorders. J Stud Alcohol Drugs Suppl. 2014;75(supplement17):59–67. http://www.ncbi.nlm.nih.gov/pubmed/24565312. Accessed September 6, 2017.
- Kilpatrick DG, Acierno R, Saunders B, Resnick HS, Best CL, Schnurr PP. Risk factors for adolescent substance abuse and dependence: data from a national sample. J Consult Clin Psychol. 2000;68(1):19–30. http://www.ncbi.nlm.nih.gov/pubmed/10710837.
- Groenman AP, Janssen TWP, Oosterlaan J. Childhood psychiatric disorders as risk factor for subsequent substance abuse: A meta-analysis. J Am Acad Child Adolesc Psychiatry. 2017;56(7):556–569.
- US Preventive Services Task Force. Draft recommendation statement: Illicit drug use, including nonmedical use of prescription drugs: screening. https://www.uspreventiveservicestaskforce.org/Page/Document/draft-recommendation-statement/drug-use-in-adolescents-and-adults-including-pregnant-women-screening. Published 2019. Accessed September 17, 2019.
- Sullivan MD, Edlund MJ, Zhang L, Unützer J, Wells KB. Association between mental health disorders, problem drug use, and regular prescription opioid use. Arch Intern Med. 2006;166(19):2087–2093.
- Koob GF, Volkow ND. Neurobiology of addiction: a neurocircuitry analysis. Lancet Psychiatry. 2016;3(8):760–773.
- Volkow N, Koob G, McLellan A. Neurobiologic Advances from the brain disease model of addiction. N Engl J Med. 2016;374(4):363–371. http://www.nejm.org/doi/full/10.1056/NEJMra1511480. Accessed February 8, 2016.
- Han BH, Moore AA, Ferris R, Palamar JJ. Binge drinking among older adults in the United States, 2015 to 2017. J Am Geriatr Soc. 2019;67(10):2139–2144.
- Anton RF. Naltrexone for the management of alcohol dependence. N Engl J Med. 2008;359(7):715–721.
- McLellan AT, Lewis DC, O'Brien CP, Kleber HD. Drug dependence, a chronic medical illness: Implications for treatment, insurance, and outcomes evaluation. JAMA. 2000;284(13):1689–1695.
- Botticelli MP, Koh HK. Changing the language of addiction. JAMA. 2016;316(13):1361–1362.
- Friedmann PD, Schwartz RP. Just call it “treatment.” Addict Sci Clin Pract. 2012;7:10.
- Haack MR, Adger H. Executive summary: strategic plan for interdisciplinary faculty development: arming the nation’s health professional workforce for a new approach to substance use disorders. Subst Abus. 2002;23(sup1):1–21.
- Broyles LM, Binswanger IA, Jenkins JA, et al. Confronting inadvertent stigma and pejorative language in addiction scholarship: a recognition and response. Subst Abus. 2014;35(3):217–221.
- Kelly JF, Westerhoff CM. Does it matter how we refer to individuals with substance-related conditions? A randomized study of two commonly used terms. Int J Drug Policy. 2010;21(3):202–207.
- Kelly JF, Wakeman SE, Saitz R. Stop talking “dirty”: clinicians, language, and quality of care for the leading cause of preventable death in the United States. Am J Med. 2015;128(1):8–9.
- The American Board of Psychiatry and Neurology. The Addiction Psychiatry Milestone Project The Accreditation Council for Graduate Medical Education and The American Board of Psychiatry and Neurology: 2015.
- ACGME. ACGME Program Requirements for Graduate Medical Education in Addiction Medicine. 2013.
- Ayu AP, el-Guebaly N, Schellekens A, et al. Core addiction medicine competencies for doctors: an international consultation on training. Subst Abus. 2017;38(4):483–487.
- Compton WM, Jones CM, Baldwin GT. Relationship between nonmedical prescription-opioid use and heroin use. Longo DL, ed. N Engl J Med. 2016;374(2):154–163.
- SAMHSA-HRSA Center for Integrated Health Solutions. Training/Other Resources [Webpage]. Available at: https://www.integration.samhsa.gov/clinical-practice/sbirt/training-other-resources. Accessed October 25, 2019.
- Opioid Response Network. Home Page [Webpage]. Available at: https://opioidresponsenetwork.org/. Accessed October 25, 2019.
- Providers Clinical Support System. About PCSS [Webpage]. Available at: https://pcssnow.org/about/. Accessed April 2, 2019.
- Clinical Addiction Research & Education (CARE) Unit.Chief Resident Immersion Training (CRIT) Program in Addiction Medicine [Webpage]. Available at: http://www.bumc.bu.edu/care/education-and-training-programs/crit/. Accessed October 25, 2019.
- Truncali A, Kalet AL, Gillespie C, et al. Engaging health professional students in substance abuse research: development and early evaluation of the SARET program. J Addict Med. 2012;6(3):196–204.
- Alford DP, Bridden C, Jackson AH, et al. Promoting substance use education among generalist physicians: an evaluation of the Chief Resident Immersion Training (CRIT) program. J Gen Intern Med. 2009;24(1):40–47.
- Opioid Analgesics REMS Program Companies. Opioid Analgesic REMS [Webpage]. Available at: https://opioidanalgesicrems.com/RpcUI/home.u. Accessed October 25, 2019.
- Cepeda MS, Coplan PM, Kopper NW, Maziere J-Y, Wedin GP, Wallace LE. ER/LA Opioid Analgesics REMS: overview of ongoing assessments of its progress and its impact on health outcomes. Pain Med. 2017;18(1):78–85.
- CDC Injury Center. Training for Providers Drug Overdose [Webpage]. Available at: https://www.cdc.gov/drugoverdose/training/index.html. Accessed October 25, 2019.
- Rosenblatt RA, Andrilla CHA, Catlin M, Larson EH. Geographic and specialty distribution of US physicians trained to treat opioid use disorder. Ann Fam Med. 2015;13(1):23–26.
- Saitz R. Unhealthy alcohol use. N Engl J Med. 2005;352(6):596–607.
- Edelman EJ, Fiellin DA. Alcohol use in the clinic. Ann Intern Med. 2016;164(1):ITC1–ITC16.
- Committee on Substance Abuse. Alcohol use by youth and adolescents: a pediatric concern. Pediatrics. 2010;125(5):1078–1087.
- Siqueira L, Smith VC, Committee on Substance Abuse. Binge drinking. Pediatrics. 2015;136(3):e718–26.
- Williams JF, Smith VC. Clinical report guidance for the clinician in rendering pediatric care fetal alcohol spectrum disorders from the American Academy of Pediatrics. Pediatrics. 2015;136(5):e1395–406.
- Tan CH, Denny CH, Cheal NE, Sniezek JE, Kanny D. Alcohol use and binge drinking among women of childbearing age – United States, 2011-2013. MMWR Morb Mortal Wkly Rep. 2015;64(37):1042–1046.
- Volkow ND, Baler RD, Compton WM, Weiss S. Adverse health effects of marijuana use. N Engl J Med. 2014;370(23):2219–2227.
- Sinha S, Shah A. Pharmacotherapy of tobacco use disorder. Am J Psychiatry Resid J. 2016;11(9):8–12.
- Ebbert JO, Agunwamba AA, Rutten LJ. Counseling patients on the use of electronic cigarettes. Mayo Clin Proc. 2015;90(1):128–134.
- Hill J, Alford DP. Prescription medication misuse. Semin Neurol. 2018;38(06):654–664.
- Boyd CJ, Cranford JA, McCabe SE. Longitudinal trajectories of non-medical use of prescription medication among middle and high school students. J Addict Dis. 2016;35(4):258–265.
- Bachhuber MA, Hennessy S, Cunningham CO, Starrels JL. Increasing benzodiazepine prescriptions and overdose mortality in the United States, 1996-2013. Am J Public Health. 2016;106(4):686–688.
- Popova S, Lange S, Probst C, Parunashvili N, Rehm J. Prevalence of alcohol consumption during pregnancy and fetal alcohol spectrum disorders among the general and aboriginal populations in Canada and the United States. Eur J Med Genet. 2017;60(1):32–48.
- Denny CH, Acero CS, Naimi TS, Kim SY. Consumption of alcohol beverages and binge drinking among pregnant women aged 18-44 years – United States, 2015-2017. MMWR Morb Mortal Wkly Rep. 2019;68(16):365–368.
- Gunn JKL, Rosales CB, Center KE, et al. Prenatal exposure to cannabis and maternal and child health outcomes: a systematic review and meta-analysis. BMJ Open. 2016;6(4):e009986.
- Committee on Substance Abuse. Substance use screening, brief intervention, and referral to treatment for pediatricians. Pediatrics. 2011;128(5):e1330–e1340.
- Ammerman S, Ryan S, Adelman WP, Committee on Substance Abuse and Committee on Adolescence. The impact of marijuana policies on youth: Clinical, research, and legal update. Pediatrics. 2015;135(3):e769. January peds.2014-4146-. http://pediatrics.aappublications.org/content/early/2015/01/20/peds.2014-4147.abstract. Accessed February 5, 2015.
- Kuerbis A, Sacco P, Blazer DG, Moore AA. Substance abuse among older adults. Clin Geriatr Med. 2014;30(3):629–654.
- Center for Behavioral Health Statistics and Quality. Key Substance Use and Mental Health Indicators in the United States: Results from the 2015 National Survey on Drug Use and Health. 2016. http://www.samhsa.gov/data/sites/default/files/NSDUH-FFR1-2015/NSDUH-FFR1-2015/NSDUH-FFR1-2015.pdf.
- Johnston L, O’Malley P, Miech R, Bachman J, Schulenberg J. Monitoring the Future national survey results on drug use, 1975-2016: Overview, key findings on adolescent drug use. Monitoring Future National Survey Results on Drug Use. 2017. http://www.monitoringthefuture.org/pubs/monographs/mtf-overview2016.pdf. Accessed July 27, 2017.
- World Health Organization. WHO WMH-CIDI – The World Health Organization World Mental Health Composite International Diagnostic Interview. https://www.hcp.med.harvard.edu/wmhcidi/. Accessed May 23, 2017.
- Hingson RW, Heeren T, Winter MR. Age at drinking onset and alcohol dependence: Age at onset, duration, and severity. Arch Pediatr Adolesc Med. 2006;160(7):739–746.
- Felitti V. The relation between adverse childhood experiences and adult health: turning gold into lead. Perm J. 2002;6(1):44–47. https://www.clark.wa.gov/sites/default/files/fileattachments/public_health/meeting/17431/goldtolead.pdf. Accessed April 12, 2018.
- Whiteford HA, Degenhardt L, Rehm J, et al. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet. 2013;382(9904):1575–1586.
- Hoffman SJ, Tan C. Overview of systematic reviews on the health-related effects of government tobacco control policies. BMC Public Health. 2015;15(1):1–11.
- World Health Organization. Alcohol: Fact Sheet. WHO. http://www.who.int/mediacentre/factsheets/fs349/en/. Published 2015. Accessed April 12, 2018.
- World Health Organization. Global Status Report on Alcohol and Health. 2011. http://apps.who.int/iris/bitstream/handle/10665/44499/9789241564151_eng.pdf;jsessionid=C463975F7B780D11596109B173272E85?sequence=1. Accessed April 12, 2018.
- National Academies of Sciences E and M. The Health Effects of Cannabis and Cannabinoids. Washington, D.C.: National Academies Press; 2017.
- Chou R, Deyo R, Devine B, et al. The Effectiveness and Risks of Long-Term Opioid Treatment of Chronic Pain. Evidence Reports/Technology Assessments, No. 218. AHRQ Publication No. 14-E005-EF. September 2014.
- Jamison RN, Mao J. Opioid analgesics. Mayo Clin Proc. 2015;90(7):957–968.
- Uzun S, Kozumplik O, Jakovljević M, Sedić B. Side effects of treatment with benzodiazepines. Psychiatr Danub 2010;22(1):90–93. http://www.ncbi.nlm.nih.gov/pubmed/20305598. Accessed April 12, 2018.
- Conti EC, Stanley MA, Amspoker AB, Kunik ME. Sedative-hypnotic use among older adults participating in anxiety research. Int J Aging Hum Dev. 2017;85(1):3–17.
- Lineberry TW, Bostwick JM. Methamphetamine abuse: a perfect storm of complications. Mayo Clin Proc. 2006;81(1):77–84.
- Lange RA, Hillis LD. Cardiovascular complications of cocaine use. N Engl J Med. 2001;345(5):351–358.
- McCabe SE, West BT. Medical and nonmedical use of prescription stimulants: results from a national multicohort study. J Am Acad Child Adolesc Psychiatry. 2013;52(12):1272–1280.
- Jessor R. Problem behavior theory: a half-century of research on adolescent behavior and development. In: Lerner R, Petersen A, Silbereisen R, Brooks-Gunn J, eds. The Developmental Science of Adolescence: History through Autobiography. New York, NY: Psychology Press; 2014:239–256. http://www.colorado.edu/ibs/jessor/pubs/Jessor-2014_ProblemBehaviorTheory_AHalf-CenturyofResearch.pdf. Accessed September 11, 2017.
- Harstad E, Levy S, Committe on Substance Abuse. Attention-deficit/hyperactivity disorder and substance abuse. Pediatrics. 2014;134(1):e293–e301. http://pediatrics.aappublications.org/content/134/1/e293. Accessed September 29, 2014.
- McCormack RP, Hoffman LF, Norman M, Goldfrank LR, Norman EM. Voices of homeless alcoholics who frequent Bellevue Hospital: A qualitative study. Ann Emerg Med. 2015;65(2):178–186.e6.
- Tsemberis S, Kent D, Respress C. Housing stability and recovery among chronically homeless persons with co-occuring disorders in Washington, DC. Am J Public Health. 2012;102(1):13–16.
- Smith VC, Wilson CR, Committee on Substance Use and Prevention. Families affected by parental substance use. Pediatrics. 2016;138(2):e20161575.
- Awad S. Confused by Confidentiality? A Primer on 42 CFR Part 2. American Society of Addiction Medicine. https://www.asam.org/resources/publications/magazine/read/article/2013/08/15/confused-by-confidentiality-a-primer-on-42-cfr-part-2. Published 2013. Accessed April 12, 2018.
- Ford C, English A, Sigman G, Center for Adolescent Health & the Law. Confidential health care for adolescents: Position paper of the society for adolescent medicine. J Adolesc Heal. 2004;35(2):160–167.
- Committee on Adolescence. Achieving quality health services for adolescents. Pediatrics. 2016;138(2):e20161347.
- Marsden J, Stillwell G, Jones H, et al. Does exposure to opioid substitution treatment in prison reduce the risk of death after release? A national prospective observational study in England. Addiction. 2017;112(8):1408–1418.
- Gourlay DL, Heit HA, Almahrezi A. Universal precautions in pain medicine: A rational approach to the treatment of chronic pain. Pain Med. 2005;6(2):107–112.
- Passik SD. Issues in long-term opioid therapy: unmet needs, risks, and solutions. Mayo Clin Proc. 2009;84(7):593–601.
- Ashery RS, Elizabeth Robertson DB, Kumpfer KL. Drug Abuse Prevention through Family Interventions. NIDA Research Monograph 177. 1998. https://archives.drugabuse.gov/sites/default/files/monograph177_0.pdf. Accessed Apri, L 12, 2018.
- Patnode CD, Perdue LA, Rushkin M, O’Connor EA. Evidence Synthesis Number 186: Screening for illicit drug use, including nonmedical use of prescription drugs: An updated systematic review for the U.S. Preventive Services Task Force. Agency Healthc Res Qual 2019;211.
- Jonas DE, Garbutt JC. Screening and counseling for unhealthy alcohol use in primary care settings. Med Clin North Am. 2017;101(4):823–837.
- National Institute on Alcohol Abuse and Alcoholism (US). Alcohol Screening and Brief Intervention for Youth: A Practitioner’s Guide. National Institute on Alcohol Abuse and Alcoholism, US Department of Health and Human Services, National Institutes of Health; 2011. https://pubs.niaaa.nih.gov/publications/Practitioner/YouthGuide/YouthGuide.pdf. Accessed July 20, 2018.
- Kaner EFS, Beyer F, Dickinson HO, et al. Effectiveness of brief alcohol interventions in primary care populations. Cochrane Database Syst Rev. 2007;(2):CD004148. http://www.ncbi.nlm.nih.gov/pubmed/17443541. Accessed October 31, 2015.
- Moyer VA, Preventive Services Task Force. Screening and behavioral counseling interventions in primary care to reduce alcohol misuse: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2013;159(3):210–218.
- Babor TF, Higgins-Biddle JC, Higgins PS, Gassman RA, Gould BE. Training medical providers to conduct alcohol screening and brief interventions. Subst Abus. 2004;25(1):17–26.
- Fleming M, Olsen D, Stathes H, et al. Virtual reality skills training for health care professionals in alcohol screening and brief intervention. J Am Board Fam Med. 2009;22(4):387–398.
- Gelberg L, Andersen RM, Afifi AA, et al. Project QUIT (Quit Using Drugs Intervention Trial): A randomized controlled trial of a primary care-based multi-component brief intervention to reduce risky drug use. Addiction. 2015;110(11):1777–1790.
- Marcus M, Savage C, Finnell D. Nursing roles in addressing addiction. In: Ries R, Fiellin D, Miller S, Saitz R, eds. The ASAM Principles of Addiction Medicine. 5th ed. Philadelphia, PA: Wolters Kluwer; 2014:493–500.
- Siu AL, U.S. Preventive Services Task Force. Behavioral and pharmacotherapy interventions for tobacco smoking cessation in adults, including pregnant women: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2015;163(8):622–634.
- Patel MS, Steinberg MB. In the clinic. Smoking cessation. Ann Intern Med. 2016;164(5):ITC33–48.
- Sullivan JT, Sykora K, Schneiderman J, Naranjo CA, Sellers EM. Assessment of alcohol withdrawal: The revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br J Addict 1989;84(11):1353–1357. http://www.ncbi.nlm.nih.gov/pubmed/2597811. Accessed April 12, 2018.
- Wesson DR, Ling W. The Clinical Opiate Withdrawal Scale (COWS). J Psychoactive Drugs. 2003;35(2):253–259.
- Srisurapanont M, Jarusuraisin N, Jittiwutikan J. Amphetamine withdrawal: I. reliability, validity and factor structure of a measure. Aust N Z J Psychiatry. 1999;33(1):89–93.
- Busto UE, Sykora K, Sellers EM. A clinical scale to assess benzodiazepine withdrawal. J Clin Psychopharmacol 1989;9(6):412–416. http://www.ncbi.nlm.nih.gov/pubmed/2574193. Accessed April 12, 2018.
- Fiellin DA, Pantalon MV, Chawarski MC, et al. Counseling plus buprenorphine–naloxone maintenance therapy for opioid dependence. N Engl J Med. 2006;355(4):365–374.
- Kampman K, Jarvis M. American Society of Addiction Medicine (ASAM) National practice guideline for the use of medications in the treatment of addiction involving opioid use. J Addict Med. 2015;9(5):358–367.
- Volkow ND, Frieden TR, Hyde PS, Cha SS. Medication-assisted therapies — Tackling the opioidoverdose epidemic. N Engl J Med. 2014;370(22):2063–2066.
- Schuckit MA. Treatment of opioid-use disorders. Longo DL, ed. N Engl J Med. 2016;375(4):357–368.
- Substance Abuse and Mental Health Services Administration. Buprenorphine Waiver Management: Qualify for a Physician Waiver. https://www.samhsa.gov/medication-assisted-treatment/buprenorphine-waiver-management/qualify-for-physician-waiver. Accessed September 7, 2017.
- Substance Abuse and Mental Health Services Administration. Qualify for Nurse Practitioners (NPs) and Physician Assistants (PAs) Waiver. https://www.samhsa.gov/programs-campaigns/medication-assisted-treatment/training-materials-resources/qualify-np-pa-waivers. Published 2018. Accessed April 12, 2018.
- Lee JD, Nunes EV, Novo P, et al. Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial. Lancet. 2018;391(10118):309–318.
- Jonas DE, Amick HR, Feltner C, et al. Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis. JAMA. 2014;311(18):1889–1900.
- Gastfriend DR. Physician substance abuse and recovery what does it mean for physicians—And everyone else?. JAMA. 2005;293(12):1513–1515.
- DuPont RL, McLellan AT, Carr G, Gendel M, Skipper GE. How are addicted physicians treated? A national survey of physician health programs. J Subst Abuse Treat. 2009;37(1):1–7.
- Argoff CE, Alford DP, Fudin J, et al. Rational urine drug monitoring in patients receiving opioids for chronic pain: Consensus recommendations. Pain Med (United States). 2018;19(1):97–117.
- American Society of Addiction Medicine. Drug Testing: A White Paper of the American Society of Addiction Medicine (ASAM). Chevy Chase, MD: American Society of Addiction Medicine; 2013. https://www.asam.org/docs/default-source/public-policy-statements/drug-testing-a-white-paper-by-asam.pdf. Accessed September 7, 2017.
- Levy S, Siqueira LM, Committee on Substance Abuse, et al. Testing for drugs of abuse in children and adolescents. Pediatrics. 2014;133(6):e1798–1807. http://www.ncbi.nlm.nih.gov/pubmed/24864184. Accessed October 16, 2014.